As a control for our in silico analysis, we validated in gastrointestinal cancer cell lines the interaction between SMYD3 and RPB1 (POLR2A), which was previously described by Hamamoto and colleagues in the HCT-116 CRC cell line [13]. The gene discussed is SMYD3; the disease is colorectal carcinoma.